1st Quarter - Report
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
Income
—
Expenses
$190,000
Expense method
C: businesses, Internal Revenue Code section 162(e)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Amending the Patent Reform Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DUTHIE | — |
Health Issues HCR
Support Eshoo/Barton Pathways to Biosimilars Act Support Kennedy Pathways to Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DUTHIE New | — |
| ROBERT D FRANKS | Member of Congress 1992-2000 |
| STEVE ISSENMAN | Congressional Page 1988-1987 Intern 1990 |
Medicare/Medicaid MMM
Advocating on behalf of Medicare Part D open access and encouraging open market access to medications
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DUTHIE | — |
| ROBERT D FRANKS | Member of Congress 1992-2000 |
Torts TOR
Oppose Medical Device Safety Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DUTHIE New | — |
| ROBERT D FRANKS | Member of Congress 1992-2000 |
Affiliated organisations
| Organisation | Location |
|---|---|
| PARTNERSHIP TO FIGHT CHRONIC DISEASE/ | Washington, DC, US |
| PHRMA | Washington, DC, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.